يعرض 1 - 10 نتائج من 491 نتيجة بحث عن '"Angioplastia Transluminal"', وقت الاستعلام: 0.96s تنقيح النتائج
  1. 1
    رسالة جامعية
  2. 2
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Cuban Journal of Cardiology and Cardiovascular Surgery; Vol. 29, No. 4 (2023): Octubre-Diciembre; e2280 ; Revista Cubana de Cardiología y Cirugía Cardiovascular; Vol. 29, No. 4 (2023): Octubre-Diciembre; e2280 ; 1561-2937

    وصف الملف: application/pdf

    العلاقة: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/2280/pdfTest; https://revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/2280/1353Test; https://revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/2280/1378Test; https://revcardiologia.sld.cu/index.php/revcardiologia/article/downloadSuppFile/2280/1379Test; World Health Organization. World health statistics 2022: monitoring health for the SDGs, sustainable development goals. Geneva; 2022. Licence: CC BY-NC-SA 3.0 IGO. [acceso 12/05/2023]. Disponible en: https://consultorsalud.com/wp-content/uploads/2022/05/Estadisticas-mundiales-OMS.pdfTest; Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud 2021. 50.a ed. La Habana: MINSAP; 2022 [acceso 12/05/2023]:212. Disponible en: https://instituciones.sld.cu/fatesa/files/2022/11/Anuario-Estad%C3%ADstico-de-Salud-2021.-Ed-2022.pdfTest; Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, et al. Association between triglyceride glucose‑body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023:22:75. DOI: https://doi.org/10.1186/s12933-023-01794-8Test; Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685-95. DOI: https://doi.org/10.1038/s41569-023-00877-zTest; Arnold SV, Bhatt DL, Barsness GW, Beatty AL, Deedwania PC, Inzucchi SE, et al. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus. Circulation. 2020 [acceso 12/05/2023];141(19):e779-e806. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32279539Test/.; Kim YH, Her AY, Rha SW, Choi CU, Choi BG, Kim JB, et al. Comparison of Clinical Outcomes after Non-ST-Segment and ST-Segment Elevation Myocardial Infarction in Diabetic and Nondiabetic Populations. J. Clin. Med. 2022;11:5079. DOI: https://doi.org/10.3390/jcm11175079Test.; Lehto HR, Winell K, Pietilä A, Niiranen TJ, Lommi J, Salomaa V. Outcomes after coronary artery bypass grafting and percutaneous coronary intervention in diabetic and non-diabetic patients. Eur Heart J - Qual Care Clin Outc. 2022;8:692-700. DOI: https://doi.org/10.1093/ehjqcco/qcab065Test; Ibáñez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci CH, Bueno H, et al. Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2017 [acceso 12/12/2021];70(12):1082.e1-e61. Disponible en: https://www.revespcardiol.org/es-pdf-S0300893217306693Test.; Schmucker J, Fach A, Osteresch R, Mata Marin LA, Ruehle S, Retzlaff T, et al. Efficacy of drug eluting stents in diabetic patients admitted with ST-elevation myocardial infarctions treated with primary percutaneous coronary intervention. J Cardiovasc Dev Dis. 2021 [acceso 26/05/2023];8(8):14. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397182/pdf/jcdd-08-00083.pdfTest.; Asociación Médica Mundial. Francia: AMM; c1947-2023. Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos. 64ª Asamblea General, Fortaleza, Brasil, octubre 2013; [acceso 01/10/2023]; [aprox. 11 p.]. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanosTest/; Crea F. Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering. Eur Heart J. 2021 [acceso 30/06/2023];42(22):2137-40. Disponible en: https://academic.oup.com/eurheartj/article/42/22/2137/6294591Test.; Rodríguez Blanco S, Almeida Gómez J, Pérez JC. Pacientes diabéticos con enfermedad coronaria multivaso tratados mediante intervencionismo coronario percutáneo. CorSalud. 2013 [acceso 13/04/2020];5(4):346-52. Disponible en: https://www.medigraphic.com/pdfs/corsalud/cor-2013/cor134d.pdfTest.; Shang C, Hernández Veliz D, Ferrer Arrocha M, Alonso Martínez MI, Pérez Assef H. Características clínico epidemiológicas del síndrome coronario agudo con elevación del ST en pacientes diabéticos y no diabéticos. Rev Cubana Cardiol. 2019 [acceso 18/02/2021];25(2):199-210. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/836Test; Aroche Aportela R, Sosa Saurí RL, Rodríguez Navarro AY, Ravelo Llanes K, Vázquez Castro F, Martínez Muñiz JO. Efectividad de la liberación local de paclitaxel en la reducción de la reestenosis postimplante de stent coronario en pacientes diabéticos. Invest. Medicoquir. 2020 [acceso 21/12/2021];12(1):1-25. Disponible en: http://revcimeq.sld.cu/index.php/imq/article/view/574Test.; Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary síndrome. Cardiovasc Diabetol. 2020 [acceso 12/05/2023];19(31):1-14. Disponible en: https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-020-01006-7.pdfTest.; Zhang Y, Chu C, Zhong Z, Luo YB, Ning FF, Guo N. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents. Front. Endocrinol. 2023;14:1101952. DOI: https://doi:10.3389/fendo.2023.1101952Test; American Diabetes Association. Cardiovascular Disease and Risk Management. Diabetes Care. 2017 [acceso 12/05/2023];40(1):S75-87. Disponible en: https://diabetesjournals.org/care/article/40/Supplement_1/S75/36817/9-Cardiovascular-Disease-and-Risk-ManagementTest; Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. Guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes (EASD). Rev Esp Cardiol. 2020 [acceso 10/11/2021];73(5):404. Disponible en: https://www.revespcardiol.org/es-pdf-S0300893220300889Test.; Hasdai D, Granger CB, Srivatsa SS, Criger DA, Ellis SG, Califf RM, et al. Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy. JACC. 2000 [acceso 28/12/2021];35(6):1502-12. Disponible en: https://doi.org/10.1016/S0735-1097Test(00)00591-X; De Boer SPM, Barnes EH, Westerhout CM, Simes RJ, Granger CB, Kastrati A, et al. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration. AHJ. 2011 [acceso 28/12/2021];161(3):500-7. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S000287031001149X?via%3DihubTest.; Neumann FJ, Sousa Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. Guía ESC/EACTS 2018 sobre revascularización miocárdica. Rev Esp Cardiol. 2019 Ene [acceso 26/05/2020];72(1):e1-e102. Disponible en: https://www.revespcardiol.org/es-pdf-S0300893218306377Test.; Farré N, Fort A, Tizón Marcos H, Recasens L, Vaquerizo B, Serrat R, et al. Epidemiología de la insuficiencia cardíaca en el infarto de miocardio tratado con angioplastia primaria: análisis de registro Codi IAM. REC: CardioClinics. 2019 [acceso 25/04/2020];54(1):41-9. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S2605153219300226Test.; Konigstein M, Perlman GY, Stone GW, Ben-Yehuda O, Golomb M, Kandzari DE, et al. Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents. J Am Coll Cardiol Intv. 2018 Dec [acceso 12/05/2021];11(24):2467-76]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1936879818320235?via%3DihubTest; https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/2280Test

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Tizón-Marcos H Hospital del Mar, Servicio de Cardiología, Barcelona, Spain. Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain. IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Vaquerizo B, Ferré JM Hospital del Mar, Servicio de Cardiología, Barcelona, Spain. Grupo de Investigación Biomédica en Enfermedades del Corazón, Barcelona, Spain. IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain. Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Mauri Ferré J Hospital Universitari GermansTrias I. Pujol, Servicio de Cardiología, Badalona, Spain. Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. Lidón RM Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Garcia-Picart J Hospital de la Santa Creu I. Sant Pau, Servicio de Cardiología, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Cardiovascular Medicine;9; https://doi.org/10.3389/fcvm.2022.847982Test; Tizón-Marcos H, Vaquerizo B, Ferré JM, Farré N, Lidón RM, Garcia-Picart J, et al. Socioeconomic Status and Prognosis of Patients With ST-Elevation Myocardial Infarction Managed by the Emergency-Intervention “Codi IAM” Network. Front Cardiovasc Med. 2022 Apr 25;9:847982.; https://hdl.handle.net/11351/8691Test; 000795594900001

  7. 7
    رسالة جامعية

    المؤلفون: Rosales Rueda, Sergio Andrés

    المساهمون: Vargas Pérez, Oliverio, Uribe Capputi, Juan Carlos, Vargas Pérez, Oliverio 0001765288, Vargas Pérez, Oliverio 0000-0003-3389-711X, Vargas Pérez, Oliverio oliverio-vargas-pérez

    الوقت: 2018-2023

    وصف الملف: application/pdf

    العلاقة: 1. Almasri J, Alsawas M, Mainou M, Mustafa RA, Wang Z, Woo K, et al. Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg 2016;64:236e43.; 2. Leermakers JJ, Bode AS, Vaidya A, van der Sande FM, Evers SM, Tordoir JH. Cost-effectiveness of vascular access for haemodialysis: arteriovenous fistulas versus arteriovenous grafts. Eur J Vasc Endovasc Surg 2013;45:84e92.; 3. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006;17:3204e12.; 4. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, et al. Dialysis Access Consortium Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008;299:2164e71.; 5. Masengu A, Maxwell AP, Hanko JB. Investigating clinical predictors of arteriovenous fistula functional patency in a European cohort. Clin Kidney J 2016;9:142e7.; 6. Roy-Chaudhury P, Spergel LM, Besarab A, Asif A, Ravani P. Biology of arteriovenous fistula failure. J Nephrol. 2007;20(2):150-163; 7. Maya ID, Oser R, Saddekni S, Barker J, Allon M. Vascular access stenosis: comparison of arteriovenous grafts and fistulas. Am J Kidney Dis. 2004;44(5):859-865; 8. Turmel-Rodrigues L, Mouton A, Birmele B, Billaux L, Ammar N, Grézard O.Salvage of immature forearm fistulas for haemodialysis by interventional radiology. Nephrol Dial Transplant 2001; 16: 2365-71; 9. Modi GK, Jha V. The incidence of end-stage renal disease in India: A population-based study. Kidney Int 2006;70:2131-3; 11. Stoumpos S, Traynor JP, Metcalfe W, Kasthuri R, Stevenson K, Mark PB, et al. A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population. J Vasc Surg 2019;69:1889-98; 12. National Kidney Foundation KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015;66:884-930. 10.1053/j.ajkd.2015.07.015; 13. Balamuthusamy S, Reddi AL, Madhrira MH, et al. Clinical predictors of recurrent stenosis and need for re-intervention in the cephalic arch in patients with brachiocephalic AV fistulas. J Vasc Access 2017;18:319-24; 14. Malka KT, Flahive J, Csizinscky A, et al. Results of repeated percutaneous interventions on failing arteriovenous fistulas and grafts and factors affecting outcomes. J Vasc Surg 2016;63:772-7. 10.1016/j.jvs.2015.09.031; 15. Suemitsu K, Shiraki T, Iida O, et al. Impact of Lesion Morphology on Durability After Angioplasty of Failed Arteriovenous Fistulas in Hemodialysis Patients. J Endovasc Ther 2018;25:649-54. 10.1177/1526602817748316; 16. Heye S, Maleux G, Vaninbroukx J, et al. Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas. Eur J Radiol 2012;81:2298-303. 10.1016/j.ejrad.2011.09.004; 17. Elramah M, Boujelbane L, Yevzlin AS, et al. Dialysis access venous stenosis: treatment with balloon angioplasty 30-second vs. 1-minute inflation times. Hemodial Int 2015;19:108-14. 10.1111/hdi.12183; 18. Higashiura W, Takara H, Kitamura R, et al. Factors Associated with Secondary Functional Patency After Percutaneous Transluminal Angioplasty of the Early Failing or Immature Hemodialysis Arteriovenous Fistula. Cardiovasc Intervent Radiol 2019;42:34-40. 10.1007/s00270-018-2083-0; 19. Lozano RN (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128; Vascular Access Group (2006) Clinical practice guidelinesfor vascular access. Am J Kidney Dis 48:248–273.; Al-Jaishi A, Oliver M, Thomas S, Lok C et al (2014) Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis 6(3):464–478; 22. Oliver MJ. The Science of Fistula Maturation. J Am Soc Nephrol. 2018 Nov;29(11):2607-2609.; 23. Dember LM, Imrey PB, Beck GJ, et al. Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis. 2014;63(1):104-112.; 24. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164-2171; 25. Al-Jaishi AA, Oliver MJ, Thomas SM, et al. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2014;63(3):464-478; 26. Palmer SC, Di Micco L, Razavian M, et al. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis. Am J Kidney Dis. 2013;61(1):112-122; 27. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204-3212.; 28. Ene-Iordache B, Cattaneo L, Dubini G, Remuzzi A. Effect of anastomosis angle on the localization of disturbed flow in “side-to-end” fistulae for haemodialysis access. Nephrol Dial Transplant. 2013;28(4):997-1005.; 29. MacRae JM, Dipchand C, Oliver M, Moist L, Lok C, Clark E, Hiremath S, Kappel J, Kiaii M, Luscombe R, Miller LM; Canadian Society of Nephrology Vascular Access Work Group. Arteriovenous Access Failure, Stenosis, and Thrombosis. Can J Kidney Health Dis. 2016 Sep 27;3:2054358116669126; 30. McLafferty RB, Pryor RW, III, Johnson CM, Ramsey DE, Hodgson KJ. Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access. J Vasc Surg. 2007;45(5):981-985; 31. Allon M, Robbin ML, Young CJ, et al. Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes. Clin J Am Soc Nephrol. 2013;8(10):1750-1755; 32. Beathard GA, Arnold P, Jackson J, Litchfield T; Physician Operators Forum of RMSL. Aggressive treatment of early fistula failure. Kidney Int. 2003;64(4):1487-1494.; 33. Riella MC, Roy-Chaudhury P. Vascular access in haemodialysis: strengthening the Achilles’ heel. Nat Rev Nephrol. 2013;9(6):348-357; 34. Chang CJ, Ko PJ, Hsu LA, et al. Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis. 2004;43(1):74-84.; Maya ID, Oser R, Saddekni S, Barker J, Allon M. Vascular access stenosis: comparison of arteriovenous grafts and fistulas. Am J Kidney Dis. 2004;44(5):859-865.; 36. Ram SJ, Work J, Caldito GC, Eason JM, Pervez A, Paulson WD. A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts. Kidney Int. 2003;64(1):272-280.; 37. Beathard GA, Litchfield T; Physician Operators Forum of Rms Lifeline I. Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists. Kidney Int. 2004;66(4):1622-1632.; 38. Kariya S, Tanigawa N, Kojima H, et al. Primary patency with cutting and conventional balloon angioplasty for different types of hemodialysis access stenosis. Radiology. 2007;243(2):578-587.; Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012;19(2):263-272; Shah A, Ansari N, Hamadeh Z. Cardiac arrest secondary to bilateral pulmonary emboli following arteriovenous fistula thrombectomy: a case report with review of the literature. Case Rep Nephrol. 2012;2012:831726; 41. Lee T, Barker J, Allon M. Needle infiltration of arteriovenous fistulae in hemodialysis: risk factors and consequences. Am J Kidney Dis. 2006;47(6):1020-1026.; 42. Ponikvar R, Premru V, Kersnic B. Surgical thrombectomy of thrombosed arteriovenous grafts by interventional nephrologists. Ther Apher Dial. 2011;15(3):306-310.; 43. Schon D, Mishler R. Pharmacomechanical thrombolysis of natural vein fistulas: reduced dose of TPA and long-term follow-up. Semin Dial. 2003;16(3):272-275.; 44. Davidson CJ, Newman GE, Sheikh KH, Kisslo K, Stack RS, Schwab SJ. Mechanisms of angioplasty in haemodialysis fistula stenoses evaluated by intravascular ultrasound. Kidney Int 1991; 40: 91-5; 45. Sands J, Young S, Miranda C. The effect of Doppler flow screening studies and elective revisions on dialysis access failure. ASAIO J 1992; 38: M524-7 46. Tan TL, May KK, Robless PA, Ho P. Outcomes of endovascular intervention; 46. Tan TL, May KK, Robless PA, Ho P. Outcomes of endovascular intervention for salvage of failing hemodialysis access. Ann Vasc Dis. 2011;4(2):87-92; 47. Lee T, Ullah A, Allon M, Succop P, El-Khatib M, Munda R, Roy-Chaudhury P. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol. 2011 Mar;6(3):575-81; Manou-Stathopoulou S, Robinson EJ, Harvey JJ, Karunanithy N, Calder F, Robson MG. Factors associated with outcome after successful radiological intervention in arteriovenous fistulas: A retrospective cohort. J Vasc Access. 2019 Nov;20(6):716-724.; 49. https://repository.unab.edu.co/handle/20.500.12749/41Test; 50. US Renal Data System 2017 USRDS Annual Data Report: executive summaryAm J Kidney Dis, 71 (3 suppl 1) (2018), pp. S1-S8; 51. O. Yoshihiro, I. Hirotoshi, and T. Shoichi, “A damp-and-push technique for the copolymer (onyx) embolization of dural arteriovenous fistula,” Journal of Stroke and Cerebrovascular Diseases, vol. 30, no. 8, pp. 566–569, 2021; 52. Asif, P. Roy-Chaudhury, G.A. Beathard Early arteriovenous fistula failure: a logical proposal for when and how to intervene Clin J Am Soc Nephrol, 1 (2) (2006), pp. 332-339.; 53. M. Yoshiki, I. Satoshi, and T. Eisuke, “A rare brainstem hemorrhage due to incomplete transvenous embolization of the cavernous sinus dural arteriovenous fistula: a case report,” Radiology Case Reports, vol. 16, no. 9, pp. 67–73, 2021.; 54. M. Priti, B. Vinant, and S. Sumit, “Stretching the boundaries: suitability of an arteriovenous fistula in elderly patients on hemodialysis-a northern India experience,” International urology and nephrology, vol. 55, no. 52, pp. 58–64, 2021.; 55. N. Hayato, F. Hiroki, and N. Takaaki, “Adjuvant heparinization before manipulation of artery reduces early failure in primary arteriovenous fistula for end-stage renal disease patients,” Clinical and experimental nephrology, vol. 25, no. 12, pp. 677–679, 2021.; 56. Suryawanshi M, Dutta P, Ganduboina R, Rajput V, Pawar SG. Standardization of Pre-operative Evaluation to Improve the Outcome of Arteriovenous Fistula for Vascular Access of Hemodialysis: A Review of 700 Cases. Cureus. 2023 Sep 26;15(9):e45999.; 57. MHuber TS, Berceli SA, Scali ST, Neal D, Anderson EM, Allon M, Cheung AK, Dember LM, Himmelfarb J, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Imrey PB, Beck GJ, Farber AM, Kaufman JS, Kraiss LW, Vongpatanasin W, Kusek JW, Feldman HI. Arteriovenous Fistula Maturation, Functional Patency, and Intervention Rates. JAMA Surg. 2021 Dec 1;156(12):1111-1118; 58. Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, et al. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011;6(8):1996–2002.; 59. Corea Cho S. The feasibility of surgical salvage of thrombosed arteriovenous fistula by an interventional nephrologist. Kidney Res Clin Pract. 2017;36(2):175–81; 60. Prasad N, Thammishetti V, Bhadauria DS, Anupama K, Sharma RK, Srivastava A, et al. Outcomes of radiocephalic fistula created by nephrologists. J Vasc Access. 2019;20(6):615–20; 61. Hod T, Desilva RN, Patibandla BK, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Factors predicting failure of AV “fistula first” policy in the elderly. Hemodial Int. 2014;18(2):507–15.; 62. Ramanan SV, Prabhu RA, Rao IR, Chawla A, Shenoy SV, Nagaraju SP, et al. Outcomes and predictors of failure of arteriovenous fistulae for hemodialysis. Int Urol Nephrol. 2022;54:185–92.; 63. Hod T, Desilva RN, Patibandla BK, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Factors predicting failure of AV “fistula first” policy in the elderly. Hemodial Int. 2014;18(2):507– Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int. 2003;63(1):346–52.; 64. Venkatnarayanan R, Dogra PM, Bavdekar R, Singh SK, Mondal AK. Primary failure of Autogenous Arteriovenous Fistula: critical analysis. Indian J Nephrol. 2020;30(6):382–90.; 65. Lazarides MK, Georgiadis GS, Antoniou GA, Staramos DN. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg. 2007;45(2):420–6.; 66. M. Monroy-Cuadros, S. Yilmaz, A. Salazar-Banuelos, C. DoigRisk factors associated with patency loss of hemodialysis vascular access within 6 monthsClin J Am Soc Nephrol, 5 (10) (2010), pp. 1787-1792.; 67. G. Pawan, K. Pushpinder, and P. Preetham, “Iatrogenic preauricular arteriovenous fistula in underlying slow-flow venous malformation and its endovascular management,” Indian Journal of Vascular and Endovascular Surgery, vol. 8, no. 3, pp. 188–192, 2021; 68. 67. Roy-Chaudhury P, Sukhatme VP, Cheung AK: Hemodialysis vascular access dysfunction: A cellular and molecular viewpoint. J Am Soc Nephrol 17: 1112–1127, 2006; Nguyen B, Duong MC, Diem Tran HN, Do KQ, Nguyen KTT. Arteriovenous fistula creation by nephrologist and its outcomes: a prospective cohort study from Vietnam. BMC Nephrol. 2023 Apr 4;24(1):88; 70. So YH, Choi YH, Oh S, Jung IM. Thrombosed native hemodialysis fistulas : Technical and clinical outcomes of endovascular recanalization and. 2019; https://apolo.unab.edu.co/en/persons/oliverio-vargas-p%C3%A9rezTest; http://hdl.handle.net/20.500.12749/23569Test; instname:Universidad Autónoma de Bucaramanga - UNAB; reponame:Repositorio Institucional UNAB; repourl:https://repository.unab.edu.coTest

  8. 8
    رسالة جامعية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المصدر: Cuban Journal of Cardiology and Cardiovascular Surgery; Vol. 25, No. 1 (2019); 75-85 ; Revista Cubana de Cardiología y Cirugía Cardiovascular; Vol. 25, No. 1 (2019); 75-85 ; 1561-2937

    وصف الملف: application/pdf; text/html

    العلاقة: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/840/pdfTest; https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/840/htmlTest; Cuba. Ministerio de Salud Pública. Dirección Nacional de Estadística. Anuario Estadístico de Salud [Internet]. La Habana: MINSAP; 2015 [citado 11 Abr 2018]. Disponible en: www.sld.cu/sitios/dne. 2. Fernández, A. Fisiopatología de la angina inestable. Papel de la rotura y trombosis de la placa aterosclerótica. Rev Esp Cardiología 1999; 52 (supl 1): 3 -12. 3. Takaro T, Pifarre R, Fish R. Veterans Administration Cooperative Study of medical versus surgical treatment for stable angina progress report. Section Left main coronary artery disease. Prog Cardiovasc Dis. 1985; 28:229–34. 4. Chieffo A, Hildick-Smith D. The European Bifurcation Club Left Main Study (EBC MAIN): rationale and design of an international, multi centre, randomised comparison of two stents strategies for the treatment of left main coronary bifurcation disease. EuroIntervention 2016; 12:47–52. 5. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, P. Banning A, Benedetto U, Byrne RA, Collet JP, Falk V. Guía ESC/EACTS 2018 sobre revascularización miocárdica. Rev Esp Cardiol. 2019; 72(1):73.e1-e102. 6. Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. JACC. 2017;69(17):2212. 7. Naranjo A, Aroche R, Hernández M, Obregón Á, Aldama L. Variabilidad Interobservador del Score SYNTAX en pacientes con diagnóstico de Enfermedad Arterial Coronaria Multivaso. Revista Cubana de Cardiología y Cirugía Cardiovascular. 2018;24(2):14. 8. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Journal of the American College of Cardiology. 2018:25285 9. Lee PH, Ahn JM, Chang M, Baek S, Yoon SH, Kang SJ, et al. Left Main Coronary Artery Disease. Secular Trends in Patient Characteristics, Treatments, and Outcomes. JACC 2016; 68 (11): 1233-1246. 10. Farooq V, Head SJ, Kappetein AP. Widening clinical applications of the SYNTAX score. Heart. 2014;100(4):276-87. 11. Leguizamón J, Azzari F, Schipani G, Chambre D, Brieva S, Fernández A, et al. Angioplastia del tronco de la arteria coronaria izquierda no protegido en pacientes con alto riesgo quirúrgico. REV ARGENT CARDIOL 2008; 76:93-99. 12. Madeira S, Raposo L, Brito J, Rodrigues R, Gonçalves P, Teles R, Gabriel H, Machado F, Almeida M, Mendes M. Potential Utility of the SYNTAX Score 2 in Patients Undergoing Left Main Angioplasty. Arq Bras Cardiol. 2016; 106(4):270-278 13. Negreiros de Andrade PJ, de Alencar Araripe Falcão JL, de Alencar Araripe Falcão B, Lima Rocha HA. Stent versus Coronary Artery Bypass Surgery in Multi-Vessel and Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Trials with Subgroups Evaluation. Arq Bras Cardiol. 2018; [online]. Doi:10.5935/abc.20190027. 14. Rodríguez Blanco S, Almeida Gómez J. Angioplastia percutánea con stent en el tronco principal de la arteria coronaria izquierda. CorSalud 2012 Oct-Dic;4(4):266-271. 15. Serrador Frutos AM, Jiménez-Quevedo P, Pérez de Prado A, Álvarez-Ossorio MP. Registro Español de Hemodinámica y Cardiología Intervencionista. XXVI Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2016) Rev Esp Cardiol. 2017;70(12):1110–1120 16. Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, et al for the EXCEL Trial Investigators. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med 2016;375:2223-35. 17. Mäkikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IBA, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016; 388: 2743–52. 18. Morice MC, Serruys PW, Kappetein AP, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial. Circulation 2014; 129: 2388-94.; https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/840Test